Greater than the sum of our parts (Malaria case study)
Building climate-resilient, sustainable, and low-carbon health supply chains: key priorities for collective action
SafeBirth Africa: Reducing preventable deaths in childbirth
Maternal and newborn health
Unitaid and the Government of Spain
Unitaid’s climate and health strategy 2023-2027
Unitaid’s investment case 2023-2027, executive summary
Unitaid’s investment case 2023-2027
Unitaid Strategy 2023-2027
Maternal and newborn health
Women’s and children’s health
Biomarkers for acute febrile illness at the point-of-care in low-resource settings. Meeting report
Accelerating access to innovative point-of-care HIV diagnostics: Lessons learned from UNICEF
Innovative delivery systems for paediatric medicines technology landscape
Disease Narrative for hepatitis C
Disease narrative for tuberculosis
Disease Narrative for malaria
Disease Narrative for HIV
Hepatitis C diagnostics technology landscape – May 2019
Unitaid audited financial report for the year ended 31 December 2021
Unitaid audited financial report for the year ended 31 December 2020
Unitaid audited financial report for the year ended 31 December 2019
Unitaid audited financial report for the year ended 31 December 2018
Global malaria diagnostic and artemisinin treatment commodities demand forecast 2017 – 2020: Policy brief (May 2017)
Tuberculosis diagnostics technology landscape – 5th edition
Unitaid at 10: Celebrating 10 years of innovation in global health
Review of the Voxilaprevir patent landscape: A scoping report
Review of the Velpatasvir patent landscape: A scoping report
Review of the Pibrentasvir patent landscape: A scoping report
Review of the Glecaprevir patent landscape: A scoping report
Unitaid at 10: Celebrating 10 years of innovation in global health (mini)
